Navigation Links
New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery
Date:1/17/2008

BOSTON, Jan. 17 /PRNewswire-USNewswire/ -- Cataract surgery involves removing a clouded natural lens from inside the eye and replacing it with a plastic one. While the operation itself hasn't changed much over recent years, the plastic lenses have. The biggest advantage of the newer lenses is their ability to reduce the need for glasses after surgery, says a newly updated report from Harvard Medical School.

The Aging Eye: Preventing and Treating Eye Disease explains that the older types of plastic lenses help people see well at one distance -- be it close up, far away, or at a medium distance. Two newer types of lenses, accommodating and multifocal, let the eye focus at varying distances, so fewer patients need glasses for reading or distance vision.

The accommodating intraocular lens has hinges on its sides that permit it to move as the eye's ciliary muscle contracts or relaxes. This improves the ability to change focus from near to far. The multifocal intraocular lens uses a new type of refractive technology to provide focus for multiple distances. This type has either small, concentric circular ridges that permit the eye to change its range of focus or broad zones to provide near, intermediate, and distance vision.

Insurers may not cover these newer lenses, and some people cannot receive them because of other medical issues. The most common problems with the newer lenses are glare, halos, and the continued need for eyeglasses.

The Aging Eye, a 48-page Special Health Report edited by Laura Fine, M.D., and Jeffrey Heier, M.D., both instructors of ophthalmology at Harvard Medical School, also covers

-- glaucoma, cataract, diabetic retinopathy, and other common eye problems

-- how diet affects eye health

-- symptoms that should send you to the ophthalmologist

-- tips for safeguarding your sight.

The Aging Eye: Preventing and Treating Eye Disease is available for $16 from Harvard Health Publications, the publishing division of Harvard Medical School. Order it online at http://www.health.harvard.edu/AE or by calling 877-649-9457 (toll-free).


'/>"/>
SOURCE Harvard Health Publications
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
2. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
3. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
4. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
5. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
6. Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
7. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
8. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
9. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
10. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
11. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... National Pharmacy Services, LLC ("Maxor"), today announced that it has ... of Texas -based Maxor Specialty / IV ... both company,s clinical expertise and high-touch patient service models to ... About Maxor ... , , Established ...
(Date:12/2/2016)... , Dec. 2, 2016 Boston Scientific Corporation ... agreement to acquire certain manufacturing assets and capabilities of ... NVC) advanced biological tissue business, as well as a ... $75 million in cash. The Neovasc advanced biological tissue ... the Boston Scientific Lotus™ Valve System. * Upon ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... ... two ostomy patients, standing as living proof that attitude and determination can combine ... and issues that spike around the holidays. This campaign will offer patients a ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to ... which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping ... prolonging life 6 years in the last 3 decades,” says Dr. Valentine Fuster, ...
(Date:12/2/2016)... ... December 02, 2016 , ... Universal Medical Systems, Inc. ... the first company to offer robotic imaging to veterinary medicine is sponsoring the ... 941 for the American Association of Equine Practitioners 62nd Annual Convention from December ...
(Date:12/2/2016)... ... ... Yisrayl Hawkins, at The House of Yahweh in Abilene, Texas, has published ... Yisrayl says this generation, known as the Last Generation, started in 1934 A.Y. (After ... up exactly with Bible Prophecy – a protected way for those who will believe. ...
(Date:12/2/2016)... ... December 02, 2016 , ... On ... individuals and families from eight different sites throughout Miami-Dade and Broward counties. This ... volunteers worked very hard on Thanksgiving morning by putting together individual meals via ...
Breaking Medicine News(10 mins):